Valuation : Unichem Laboratories Limited

Market Cap 39.16B 412M 354M 333M 304M 571M 575M 3.94B 1.53B 19.86B 1.55B 1.51B 65.76B P/E 2025
35.6x
P/E 2026 8.19x
Enterprise Value 41.27B 434M 373M 351M 320M 601M 606M 4.16B 1.62B 20.93B 1.63B 1.59B 69.29B EV / Sales 2025
2.49x
EV / Sales 2026 1.03x
Free-Float
28.74%
Yield 2025 *
-
Yield 2026 -
1 day-1.36%
1 week+5.78%
Current month+8.40%
1 month+6.27%
3 months+59.31%
6 months+68.86%
Current year+25.96%
1 week 504.05
Extreme 504.05
589.35
1 month 482.3
Extreme 482.3
600
Current year 278.2
Extreme 278.2
687.2
1 year 278.2
Extreme 278.2
687.2
3 years 278.2
Extreme 278.2
937.95
5 years 198
Extreme 198
937.95
10 years 80
Extreme 80
937.95
Manager TitleAgeSince
Chief Executive Officer 57 2023-08-09
Director of Finance/CFO - 2024-08-07
Compliance Officer - -
Director TitleAgeSince
Chairman 73 1977-08-21
Director/Board Member 53 2023-08-09
Director/Board Member 57 2023-08-09
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%+5.78% - - 415M
-1.52%-7.23%+57.90%+108.72% 1,047B
-0.82%-2.63%+50.05%+64.43% 646B
+0.37%-3.06%+21.87%+74.48% 451B
-1.64%-4.75%+35.59%+35.54% 355B
-0.39%-2.76%+21.39%+38.01% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-0.59%-3.15%+49.83%+67.70% 234B
-1.05%-2.29%-19.91%-54.10% 203B
+0.45%-0.27%+29.84%+91.34% 181B
Average -0.77%-2.91%+27.56%+48.63% 406.59B
Weighted average by Cap. -0.88%-3.94%+36.91%+64.77%

Financials

2025 2026
Net sales 21.11B 222M 191M 179M 164M 308M 310M 2.13B 827M 10.7B 833M 815M 35.44B 22.02B 231M 199M 187M 171M 321M 323M 2.22B 863M 11.17B 869M 850M 36.97B
Net income 1.38B 14.45M 12.44M 11.68M 10.67M 20.04M 20.18M 138M 53.87M 697M 54.27M 53.09M 2.31B 2.53B 26.57M 22.88M 21.48M 19.61M 36.84M 37.1M 255M 99.05M 1.28B 99.77M 97.61M 4.25B
Net Debt 3.7B 38.91M 33.5M 31.45M 28.71M 53.94M 54.32M 373M 145M 1.88B 146M 143M 6.22B 2.11B 22.14M 19.06M 17.9M 16.34M 30.7M 30.92M 212M 82.53M 1.07B 83.13M 81.33M 3.54B
Logo Unichem Laboratories Limited
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Employees
2,780
Date Price Change Volume
26-08-31 ₹556.55 -1.36% 321,470
26-08-28 ₹564.25 +4.54% 330,176
26-08-27 ₹539.75 +1.78% 102,231
26-08-26 ₹530.30 +0.81% 81,667
26-08-25 ₹526.05 +3.19% 819,498